CD5 Negative B-cell Chronic Lymphocytic Leukemia: Clinical and Biological Features of 42 cases

References

• International Workshop on Chronic Lymphocytic Leukemia. Recommendations for diagnosis, stage and response criteria. Annals of Internal Medicine 1989; 110: 236–238
   PubMed Web of Science ®Google Scholar
• Baldini L., Cro L., Cortelezzi A., Calori R., Nobili L., Maiolo A.T., Polli E.E. Immunophenotypes in “classical” B-cell chronic lymphocytic leukemia. Correlation with normal cellular counterpart and clinical findings. Cancer 1990; 66: 1738–1742
   PubMed Web of Science ®Google Scholar
• Harris L.N., Jaffe E.S., Stein H., Banks P.M., Chan J.K.C., Clearly M.L., Delsol G., De Wolf-Peters C., Falini B., Gatter K.C., Grogan T.C., Isaacson P.G., Knowles D.M., Mason D.Y., Muller-Hermlink H.K., Pileri S.A., Piris M.A., Ralfkiaer E., Warnke R.A. A revised European-American Classification of Lymphoid Neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Montserrat E., Rozman C. Chronic lymphocytic leukemia: present status. Annals of oncology 1995; 6: 219–235
   PubMed Web of Science ®Google Scholar
• Lydard P.M., Youinou P.Y., Cooke A. CD5− positive B cells in rheumatoid arthritis and chronic lymphocytic leukemia. Immunology Today 1987; 8: 37–38
   PubMedGoogle Scholar
• Kiyoi H., Naito K., Ohno R., Naoe T. Comparable profiles of the immunoglobulin heavy chain complementarity determining region (CDR)-3 in CD5+ and CD5− human cord blood B lymphocytes. Immunology 1995; 85: 236–240
   PubMed Web of Science ®Google Scholar
• Raveche E.S. Possible immunoregulatory role for CD5+ B cells. Clinical Immunology and Immunopathology 1990; 56: 135–150
   PubMedGoogle Scholar
• Shirai T., Hirose S., Okada T., Nishimura H. CD5+ B cells in autoimmune disease and lymphoid malignancy. Clinical Immunology and Immunopathology 1991; 59: 173–186
   PubMedGoogle Scholar
• Kurec A.S., Threatte G.A., Gottlieb A.J., Smith J.R., Anderson J., Davey F.R. Immunophenotypic subclassification of chronic lymphocytic leukemia. British Journal ofHaematology 1992; 81: 45–51
   PubMed Web of Science ®Google Scholar
• De Rossi G., Mauro F.R., Lo Coco F., Caruso R., Niscola P., Pasqualetti D., Mandelli F. CD5 negative lymphocytosis mimicking typical B-chronic lymphocytic leukemia. Description of 26 cases. Nouvelle Revue Francaise d'Hematologic 1993; 35: 451–455
   PubMed Web of Science ®Google Scholar
• Geisler C.H., Larsen J.K., Hansen N.E., Hansen M.M., Christensen B.E., Lund B., Nielsen H., Plesner T., Thorling K., Andersen E., Andersen P.K. Pronostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 1991; 78: 1795–1802
   PubMed Web of Science ®Google Scholar
• Binet J.L., Auquier A., Dighiero G., Chastang C., Piguet H., Goasguen J., Vaugier G., Potron G., Colona P., Oberling F., Thomas M., Tchernia G., Jacquillat C., Boivin P., Lesty C., Duault M.T., Monconduit M., Belabbes S., Gremy F. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48: 198–206
   PubMed Web of Science ®Google Scholar
• Rai R.K., Sawitsky A., Cronkite E.P., Chanana A.D., Levy R.N., Pastemack B.S. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–234
   PubMed Web of Science ®Google Scholar
• Rozman C., Montserrat E., Rodriguez-Fernandez J.M., Ayats R., Vallepsi T., Parody R., Rios A., Prados D., Morey M., Gomis F., Alcala A., Guitierrez M., Maldonado J., Gonzalez C., Giralt M., Hernandez-Nieto L., Cabrera A., Fernandez-Ranada J.M. Bone marrow histologic pattern-The best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood 1984; 64: 642–648
   PubMed Web of Science ®Google Scholar
• Kaplan E.L., Meier P. Non parametric estimation from incomplete observations. Journal American Statistic Association 1958; 53: 457–481
   Web of Science ®Google Scholar
• Peto R., Pike M.C., Armitage P., Breslow N., E'Cox D.R., Howard S.V., Mantel N., McPherson K., Peto J., Smith P.G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. British Journal of Cancer 1977; 35: 1–39
   PubMed Web of Science ®Google Scholar
• Rousselet M.C., Gardembas-Pain M., Renier G., Chevailler A., Ifrah N. Splenic lymphoma with circulating villous lymphocytes. Report of a case with immunologic and ultrastructural studies. American Journal of Clinical Pathology 1992; 97: 147–152
   PubMed Web of Science ®Google Scholar
• Mulligan S.P., Matutes E., Dearden C., Catovsky D. Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases. British Journal of Haematology 1991; 78: 206–209
   PubMed Web of Science ®Google Scholar
• Melo J.V., Catovsky D., Galton D.A.G. The relationship between chronic lymphocytic leukemia and pro-lyphocytic leukemia I. Clinical and laboratory features of 300 patients and characterisation of an intermediate group. British Journal of Haematology 1986; 63: 377–387
   PubMed Web of Science ®Google Scholar
• Salomon N., Guyen F., Valensi F., Merle-Beral H., Flandrin G. A scoring system for the classification of CD5− B CLL versus CD5+ B CLL and B PLL. Leukemia and Lymphoma 1995; 16: 445–450
   PubMed Web of Science ®Google Scholar
• Kay N.E., Peterson L. Heterogeneity of CD5 membrane expression on B-chronic lymphocytic leukemia cells. Leukemia and Lymphoma 1991; 5: 49–55
   PubMed Web of Science ®Google Scholar
• Linassier C., Bremond J.L., Georget M.T., Burachi J.P., Petit A., Poumier-Gaschard P., Fimbel P., Lamagnere J.P., Colombat P. Clinical presentation of CD5− CLL: an analysis of 26 cases. Nouvelle Revue Francaise d' Hématologic 1991; 33: 178
   Google Scholar